LeachMW, HalpernWG, JohnsonCW, RojkoJL, MacLachlanTK, ChanCM, GalbreathEJ, NdiforAM, BlansetDL, PolackE, CavagnaroJA. Use of tissue cross-reactivity studies in the development of antibody-based biopharmaceuticals: History, experience, methodology, and future directions. Toxicol. Pathol., 2010; 38: 1138–66.
2.
GeolyFJ. Tissue Cross-Reactivity Studies: What Constitutes an Adequate Positive Control and How Do We Report Positive Staining? [Regulatory Forum Opinion Piece.]. Toxicol. Pathol., 2014; 42: 954–956.
